

** Pharma about to be perceived as a growth sector again, driven by drug discoveries & accelerated US FDA approvals, says Old Mutual Global Investors'...


Deutsche Bank bumped up its price target for Shire to 6000p from 5900p. "Following a detailed analysis of Shire's pipeline and growth prospects, we be...


Beazley: JP Morgan upgrades to overweight from neutral and sets 308p target, up from 255p. Hiscox: JP Morgan upgrades to overweight from neutral and u...